Doses of Pfizer-BioNTech`s Comirnaty, Modernaâs Spikevax, AstraZenecaâs Vaxzevria and Johnson & Johnson, the first 4 vaccines approved by Health Canada, have arrived in Canada since December 2020, allowing provinces and territories to conduct their COVID-19 vaccination programs. As part of our commitment to transparency, PSPC worked with vaccine suppliers to obtain their approval of public versions of Canada`s vaccine contracts. In March 2020, the federal government announced an investment of C$275 million for ”coronavirus research and medical countermeasures”, and on April 23, 2020, additional financial support of more than C$1 billion was announced. This funding for the ”National Medical Research Strategy to Combat COVID-19” included ”vaccine development, treatment manufacturing, and virus monitoring.”  After agreeing with Pfizer to increase certain shipments, it was predicted that by the end of March 2021, a total of 8 million doses of vaccines (from three suppliers) will be available in Canada.  In order to maximize the distribution of the first doses, NACI has made a recommendation that the second doses should be administered up to four months after the first dose.  Canada built its vaccine portfolio through APAs with 7 companies. The first 2 deals with Moderna and Pfizer were announced in August 2020, followed by similar deals with Johnson & Johnson, Novavax, Sanofi and GlaxoSmithKline, AstraZeneca and Medicago. None of the vaccines in the portfolio had Canadian production capacity at the time. Canada is committed to providing a comprehensive and global response to the pandemic and is working to ensure that countries around the world have access to COVID-19 vaccines through its investments in the Covid-19 Global Vaccine Access Facility (COVAX) and the donation of surplus vaccine doses. On July 27, 2021, the Canadian government announced that Canada had reached an important milestone with the receipt of more than 66 million doses of COVID-19 vaccines. This meant that Canada had received enough doses to fully vaccinate all eligible persons in Canada. Moderna is a pioneering biotechnology company specializing in messenger RNA therapies and vaccines. The company will contribute to Canada`s biomanufacturing and life sciences strategy by leveraging its expertise in mRNA manufacturing and expanding Canada`s existing strengths in RNA research and nanomedicine technology development.
In the same week as the first vaccines for the Pfizer-BioNTech COVID-19 vaccine, Health Canada approved the Moderna vaccine on December 23 and it was announced that Canada would receive 168,000 doses of the Moderna vaccine by the end of 2020.   Unlike the Pfizer-BioNTech vaccine, Moderna`s vaccine does not require storage at extremely cold temperatures, meaning that the Northwest Territories and Yukon had received their first shipments of 7,200 pieces of Moderna`s vaccine each by December 28.  Vaccinations in the different areas are not planned until mid-January.  Quebec no longer recommends a second dose for people who have already been infected with COVID-19, as immunity is considered strong enough.  People who still want to receive a second dose are allowed to get it. 10 million doses have been carried over from the initial agreement to 2022. On May 5, 2021, Canadian health authorities approved Pfizer`s vaccine for adolescents aged 12 to 15 years, becoming the first country in the world to do so.  This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including: the Company`s development of a COVID-19 vaccine (mRNA-1273); contracts for the sale of 1273-mRNAs or other COVID-19 vaccine boosters to the Canadian government; the date of such sales; and the possibility for the Canadian government to exercise options for other purchases.
The forward-looking statements contained in this press release are neither promises nor warranties, and you should not place undue reliance on such forward-looking statements, as they involve known and unknown risks, uncertainties and other factors, many of which are beyond Moderna`s control, that could cause actual results to be material to those expressed or implied by such forward-looking statements. deviate. These risks, uncertainties and other factors include the other risks and uncertainties described under the heading ”Risk Factors” in Moderna`s most recent Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (SEC) and in Moderna`s subsequent filings with the SEC, which are available on the SEC`s website under www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility to update or revise any forward-looking statements contained in this press release as a result of new information, future developments or otherwise. These forward-looking statements are based on Moderna`s current expectations and speak only as of the date of this press release. In January 2021, the province of Saskatchewan discovered that it could derive additional doses of pfizer`s vaccine from vials labeled at 5 doses.  You are required by law to take the arrival test within the required time. If you do not comply, you cannot be exempted from quarantine.
You may also need to go to a quarantine center, face fines, or other law enforcement actions. If you have recovered from COVID-19, you will still need at least 2 doses of an accepted covid-19 vaccine or a mix of 2 accepted vaccines. Around the world, several COVID-19 vaccines are at different stages of development. As of December 2, 2020,[update], the Canadian government had invested more than $1 billion, including pre-orders for seven different vaccines, four of which are now approved for use by Health Canada. These pre-orders amount to more than 400 million doses.     Six of the seven vaccines require two doses each to be effective, with the exception of janssen Pharmaceutica (Johnson & Johnson), which requires only one dose.  No smartphone? Log in to ArriveCAN from a computer within 72 hours of arriving in Canada to receive your ArriveCAN receipt. Print your receipt and take it with you when you travel. .